Silencing NIK potentiates anti-VEGF therapy in a novel 3D model of colorectal cancer angiogenesis

Por Maracle, Chrissta X., Jeucken, Kim C.M., Helder, Boy, van Gulik, Thomas M., Steins, Anne, van Laarhoven, Hanneke W.M., Tas, Sander W.
Publicado no Oncotarget (2018)

NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis

Por Noort, Ae R, van Zoest, Katinka PM, Weijers, Ester M, Koolwijk, Pieter, Maracle, Chrissta X, Novack, Deborah V, Siemerink, Martin J, Schlingemann, Reinier O, Tak, Paul P, Tas, Sander W
Publicado em 2014

Characterization of Hemostasis in Mice lacking the Novel Thrombosis Susceptibility Gene Slc44a2

Por Tilburg, Julia, Adili, Reheman, Nair, Thankam S., Hawley, Megan E., Tuk, David C., Jackson, Madeline, Spronk, Henri M., Versteeg, Henri H., Carey, Thomas E., van Vlijmen, Bart J.M., Maracle, Chrissta X., Holinstat, Michael
Publicado no Thromb Res (2018)

SLC44A2 deficient mice have a reduced response in stenosis but not in hypercoagulability driven venous thrombosis

Por Tilburg, Julia, Coenen, Daniëlle M., Zirka, Gaia, Dólleman, Sophie, van Oeveren‐Rietdijk, Annemarie M., Karel, Mieke F. A., de Boer, Hetty C., Cosemans, Judith M. E. M., Versteeg, Henri H., Morange, Pierre E., van Vlijmen, Bart J. M., Maracle, Chrissta X., Thomas, Grace M.
Publicado no J Thromb Haemost (2020)

Rapid stromal remodeling by short‐term VEGFR2 inhibition increases chemotherapy delivery in esophagogastric adenocarcinoma

Por Steins, Anne, Klaassen, Remy, Jacobs, Igor, Schabel, Matthias C., van Lier, Monique G. J. T. B., Ebbing, Eva A., Hectors, Stefanie J., Tas, Sander W., Maracle, Chrissta X., Punt, Cornelis J. A., Siebes, Maria, Bergman, Jacques J. G. H. M., Medema, Jan Paul, Wilmink, Johanna W., Mathot, Ron A. A., Strijkers, Gustav J., Bijlsma, Maarten F., van Laarhoven, Hanneke W. M.
Publicado no Mol Oncol (2020)